|
"jia horng kao"的相关文件
显示项目 76-85 / 1180 (共118页)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2021-12-14T23:12:07Z |
Withdrawal of Nucleos(t)ide Analogues in Hepatitis B e Antigen–Negative Patients: An Asian Perspective
|
TUNG-HUNG SU; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-12-14T23:11:55Z |
Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan
|
CHUN-MING HONG; Lin, You Yu; CHUN-JEN LIU; Lai, Ya Yun; Shiou-Hwei Yeh; HUNG-CHIH YANG; JIA-HORNG KAO; Hsu, Shih Jer; Huang, Yi Hsiang; Yang, Sheng Shun; Kuo, Hsing Tao; Cheng, Pin Nan; Yu, Ming Lung; PEI-JER CHEN |
| 臺大學術典藏 |
2021-10-21T23:27:15Z |
Paradigm shift in the treatment options of hepatocellular carcinoma
|
TUNG-HUNG SU; Hsu, Shih Jer; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-10-21T23:27:05Z |
Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients (Hepatology International, (2021), 15, 3, (582-592), 10.1007/s12072-021-10186-7)
|
Cheng, Huei Ru; HUNG-CHIH YANG; Lin, Su Ru; Yang, Ta Yu; Lin, You Yu; TUNG-HUNG SU; Tseng, Tai Chung; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-10-21T23:27:05Z |
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents
|
Huang, Shang Chin; Cheng, Pin Nan; CHEN-HUA LIU; HUNG-CHIH YANG; TUNG-HUNG SU; Tseng, Tai Chung; PEI-JER CHEN; JIA-HORNG KAO; CHUN-JEN LIU |
| 臺大學術典藏 |
2021-09-14T23:18:54Z |
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Yeh, Ming Lun; Hung, Chao Hung; Tseng, Kuo Chih; Lai, Hsueh Chou; Chen, Chi Yi; Kuo, Hsing Tao; Wang, Jing Houng; Chen, Jyh Jou; Lee, Pei Lun; Chien, Rong Nan; Yang, Chi Chieh; Lo, Gin Ho; Tai, Chi Ming; Lin, Chih Wen; JIA-HORNG KAO; CHEN-HUA LIU; Yan, Sheng Lei; Bair, Ming Jong; Lin, Chun Yen; Su, Wei Wen; Chu, Cheng Hsin; Chen, Chih Jen; Tung, Shui Yi; Lo, Ching Chu; Cheng, Pin Nan; Chiu, Yen Cheng; CHIA-CHI WANG; Cheng, Jin Shiung; Tsai, Wei Lun; Lin, Han Chieh; Huang, Yi Hsiang; Huang, Chung Feng; Huang, Jee Fu; Dai, Chia Yen; Chuang, Wan Long; Tsai, Pei Chien; Peng, Cheng Yuan; CHUN-JEN LIU; Yu, Ming Lung |
| 臺大學術典藏 |
2021-09-14T23:18:41Z |
Systemic therapy for hepatocellular carcinoma: New agents and therapeutic hierarchy
|
TUNG-HUNG SU; Hsu, Shih Jer; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-14T23:18:28Z |
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis
|
TUNG-HUNG SU; Peng, Cheng Yuan; Chang, Shan Han; Tseng, Tai Chung; CHUN-JEN LIU; CHI-LING CHEN; CHEN-HUA LIU; HUNG-CHIH YANG; PEI-JER CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:24:24Z |
Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C
|
Yang P.-M.; Hwang L.-H.; Lai M.-Y.; Huang W.-L.; Chu Y.-D.; Chi W.-K.; Chiang B.-L.; JIA-HORNG KAO; Chen P.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:24:24Z |
Reply To the Editor
|
Lin H.-H.; JIA-HORNG KAO; Chen P.-J.; Chen D.-S. |
显示项目 76-85 / 1180 (共118页)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每页显示[10|25|50]项目
|
